NEW YORK (GenomeWeb News) – Avanticell Science said yesterday that it will head a consortium that includes Giltech and Culzean Medical Devices in developing three-dimensional cell-based assay systems for drug discovery research.

Avanticell specializes in cell culture products and services, Culzean Medical Devices designs and makes implantable medical products, and Giltech makes biomaterials and biodegradable products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.